Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Masato Hamasaki"'
Autor:
Masaki Sato, Edward B. Neufeld, Martin P. Playford, Yu Lei, Alexander V. Sorokin, Angel M. Aponte, Lita A. Freeman, Scott M. Gordon, Amit K. Dey, Kianoush Jeiran, Masato Hamasaki, Maureen L. Sampson, Robert D. Shamburek, Jingrong Tang, Marcus Y. Chen, Kazuhiko Kotani, Josephine L.C. Anderson, Robin P.F. Dullaart, Nehal N. Mehta, Uwe J.F. Tietge, Alan T. Remaley
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 18 (2023)
BACKGROUND Cellular cholesterol efflux capacity (CEC) is a better predictor of cardiovascular disease (CVD) events than HDL-cholesterol (HDL-C) but is not suitable as a routine clinical assay.METHODS We developed an HDL-specific phospholipid efflux (
Externí odkaz:
https://doaj.org/article/39566e9a46204437a84f2a721f256ea3
Publikováno v:
Annals of Clinical & Laboratory Science; May/Jun2024, Vol. 54 Issue 3, p419-422, 4p
Publikováno v:
Acta bio-medica : Atenei Parmensis. 93(6)
Gain-of-function (GOF) variants of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene cause high blood low-density lipoprotein (LDL) cholesterol and PCSK9 levels, which are respectively the markers of cardiovascular disease (CVD). High blood
Publikováno v:
Archives of Medical Sciences. Atherosclerotic Diseases
IntroductionLipoprotein(a) (Lp[a]) is a risk factor of cardiovascular disease (CVD). Familial hypercholesterolemia (FH), which exhibits high low-density lipoprotein cholesterol (LDL-C) levels, is a risk factor of CVD. The relationship of Lp(a) with C
Autor:
Masato Hamasaki, Kazuhiko Kotani
Publikováno v:
Cardiology Research
Lipoprotein(a) (Lp(a)) and low-density lipoprotein cholesterol (LDL-C) are risk factors for cardiovascular disease (CVD). Individuals with familial hypercholesterolemia (FH) have a risk for CVD due to a high LDL-C value. Lp(a) also increases the CVD
Publikováno v:
Journal of Clinical Laboratory Analysis
Background Familial hypercholesterolemia (FH), an autosomal dominant genetic disease with the elevated levels of low‐density lipoprotein (LDL) cholesterol (LDL‐C), increases the risk of coronary artery disease (CAD). The proprotein convertase sub
Autor:
Lita A. Freeman, Kazuo Hara, Alan T. Remaley, Masaki Sato, Masato Hamasaki, Kazuhiko Kotani, Norimitsu Hosaka
Publikováno v:
Biochimica et biophysica acta. General subjects. 1866(2)
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in regulating low-density lipoprotein levels in plasma. While PCSK9 variants are causatively associated with familial hypercholesterolemia (FH), additional genotyping m
Autor:
Yuji Segawa, Tsugunori Notomi, Toshihiro Yonekawa, Shota Yuki, Norimitsu Hosaka, Masato Hamasaki, Shohei Semba, Masaki Sato, Hidetoshi Watanabe, Shiori Sano, Atsushi Shoji
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Nucleic acid amplification-based diagnostics is known as one of the molecular diagnostic systems that allows higher sensitive detection of pathogens than test methods such as immunoassay. However, it has not been widely used because it is complicated
Autor:
Masato Hamasaki1, Kohsuke Hazeyama1, Fumihiko Iwasaki2, Toshifumi Ueda2, Takashi Nakashima1,2, Yoshimitsu Kakuta1,2, Makoto Kimura1,2 mkimura@agr.kyushu-u.ac.jp
Publikováno v:
Journal of Biochemistry. Jan2016, Vol. 159 Issue 1, p31-40. 10p. 4 Diagrams, 2 Charts, 3 Graphs.
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 904, p 904 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine
Introduction: Helicobacter pylori (H. pylori) infection is positively associated with cardiovascular diseases, but the involvement of lipids in this association remains unclear. The present study reviewed the changes in circulating lipid levels follo